Friday, November 9, 2018

Strides’ unit inks pact with SUDA Pharmaceuticals for migraine drug

Strides Pharma Science’s step-down subsidiary has entered into an exclusive product development, licensing and supply agreement with Australia’s SUDA
Source: BHT
Share This
Previous Post
Next Post

Pellentesque vitae lectus in mauris sollicitudin ornare sit amet eget ligula. Donec pharetra, arcu eu consectetur semper, est nulla sodales risus, vel efficitur orci justo quis tellus. Phasellus sit amet est pharetra